doi.org· Human vaccines & immunotherapeutics·· 2 days agoScore56
Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China
In brief
A randomized, open-label Phase IV trial in China showed that sequential co-administration of WIBP-CorV with PPV23 and IIV4 on Day 0 and Day 28 maintained humoral immune responses against three respiratory pathogens in adults.
Source: doi.org · doi.org